Literature DB >> 23943405

Murine model of disseminated fusariosis: evaluation of the fungal burden by traditional CFU and quantitative PCR.

Gloria M González1, Jazmín Márquez, Rogelio de J Treviño-Rangel, José P Palma-Nicolás, Elvira Garza-González, Luis A Ceceñas, J Gerardo González.   

Abstract

Systemic disease is the most severe clinical form of fusariosis, and the treatment involves a challenge due to the refractory response to antifungals. Treatment for murine Fusarium solani infection has been described in models that employ CFU quantitation in organs as a parameter of therapeutic efficacy. However, CFU counts do not precisely reproduce the amount of cells for filamentous fungi such as F. solani. In this study, we developed a murine model of disseminated fusariosis and compared the fungal burden with two methods: CFU and quantitative PCR. ICR and BALB/c mice received an intravenous injection of 1 × 10(7) conidia of F. solani per mouse. On days 2, 5, 7, and 9, mice from each mice strain were killed. The spleen and kidneys of each animal were removed and evaluated by qPCR and CFU determinations. Results from CFU assay indicated that the spleen and kidneys had almost the same fungal burden in both BALB/c and ICR mice during the days of the evaluation. In the qPCR assay, the spleen and kidney of each mouse strain had increased fungal burden in each determination throughout the entire experiment. The fungal load determined by the qPCR assay was significantly greater than that determined from CFU measurements of tissue. qPCR could be considered as a tool for quantitative evaluation of fungal burden in experimental disseminated F. solani infection.

Entities:  

Mesh:

Year:  2013        PMID: 23943405     DOI: 10.1007/s11046-013-9687-3

Source DB:  PubMed          Journal:  Mycopathologia        ISSN: 0301-486X            Impact factor:   2.574


  21 in total

Review 1.  The epidemiology of fusariosis in patients with haematological diseases. Gimema Infection Programme.

Authors:  C Girmenia; L Pagano; L Corvatta; L Mele; A del Favero; P Martino
Journal:  Br J Haematol       Date:  2000-10       Impact factor: 6.998

2.  Comparison of antifungal treatments for murine fusariosis.

Authors:  Brad Spellberg; Julie Schwartz; Yue Fu; Valentina Avanesian; Jill Adler-Moore; John E Edwards; Ashraf S Ibrahim
Journal:  J Antimicrob Chemother       Date:  2006-09-14       Impact factor: 5.790

3.  Tissue homogenization with sterile reinforced polyethylene bags for quantitative culture of Candida albicans.

Authors:  T J Walsh; C McEntee; D M Dixon
Journal:  J Clin Microbiol       Date:  1987-05       Impact factor: 5.948

4.  Voriconazole treatment for less-common, emerging, or refractory fungal infections.

Authors:  John R Perfect; Kieren A Marr; Thomas J Walsh; Richard N Greenberg; Bertrand DuPont; Juliàn de la Torre-Cisneros; Gudrun Just-Nübling; Haran T Schlamm; Irja Lutsar; Ana Espinel-Ingroff; Elizabeth Johnson
Journal:  Clin Infect Dis       Date:  2003-04-22       Impact factor: 9.079

5.  Posaconazole as salvage treatment for invasive fusariosis in patients with underlying hematologic malignancy and other conditions.

Authors:  Issam I Raad; Ray Y Hachem; Raoul Herbrecht; John R Graybill; Roberta Hare; Gavin Corcoran; Dimitrios P Kontoyiannis
Journal:  Clin Infect Dis       Date:  2006-04-11       Impact factor: 9.079

6.  Efficacy of posaconazole as treatment and prophylaxis against Fusarium solani.

Authors:  Nathan P Wiederhold; Laura K Najvar; Rosie Bocanegra; John R Graybill; Thomas F Patterson
Journal:  Antimicrob Agents Chemother       Date:  2010-01-11       Impact factor: 5.191

Review 7.  Clinical patterns of Fusarium infections in immunocompromised patients.

Authors:  P Martino; R Gastaldi; R Raccah; C Girmenia
Journal:  J Infect       Date:  1994-05       Impact factor: 6.072

8.  Antifungal susceptibility profile of clinical Fusarium spp. isolates identified by molecular methods.

Authors:  Ana Alastruey-Izquierdo; Manuel Cuenca-Estrella; Araceli Monzón; Emilia Mellado; Juan Luís Rodríguez-Tudela
Journal:  J Antimicrob Chemother       Date:  2008-02-08       Impact factor: 5.790

Review 9.  Fusarium infections in immunocompromised patients.

Authors:  Marcio Nucci; Elias Anaissie
Journal:  Clin Microbiol Rev       Date:  2007-10       Impact factor: 26.132

10.  The changing spectrum of fungal keratitis in south Florida.

Authors:  R H Rosa; D Miller; E C Alfonso
Journal:  Ophthalmology       Date:  1994-06       Impact factor: 12.079

View more
  2 in total

Review 1.  Janus-Faced Molecules against Plant Pathogenic Fungi.

Authors:  Gaspar Banfalvi
Journal:  Int J Mol Sci       Date:  2021-11-15       Impact factor: 5.923

2.  Murine model for Fusarium oxysporum invasive fusariosis reveals organ-specific structures for dissemination and long-term persistence.

Authors:  Katja Schäfer; Antonio Di Pietro; Neil A R Gow; Donna MacCallum
Journal:  PLoS One       Date:  2014-02-27       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.